M. Martorelli

Most-cited papers

1. Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

   G. D'Arena, P. Gobbi, C. Broglia, S. Sacchi +12 more

   2011Leukemia and Lymphoma101 citations Open access

   Semantic Scholar

   Save

2. Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia

   P. Musto, V. Simeon, M. Martorelli, Maria Teresa Petrucci +26 more

   2014Leukemia94 citations Open access

   Semantic Scholar

   Save

3. Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party.

   G. D'Arena, C. Valentini, G. Pietrantuono, R. Guariglia +14 more

   2012Annals of Oncology88 citations

   Semantic Scholar

   Save

4. Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review.

   R. Guariglia, M. Martorelli, O. Villani, G. Pietrantuono +7 more

   2011Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis66 citations

   Semantic Scholar

   Save

5. A shorter time to the first treatment may be predicted by the absolute number of regulatory T‐cells in patients with Rai stage 0 chronic lymphocytic leukemia

   G. D'Arena, F. D'Auria, V. Simeon, L. Laurenti +12 more

   2012American journal of hematology/oncology38 citations

   Semantic Scholar

   Save

6. Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia.

   P. Musto, G. Pietrantuono, R. Guariglia, O. Villani +4 more

   2008Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis37 citations

   Semantic Scholar

   Save

7. Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes.

   P. Musto, O. Villani, M. Martorelli, G. Pietrantuono +10 more

   2010Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis25 citations

   Semantic Scholar

   Save

8. Biologics: Targets and Therapy Dovepress Lipegfilgrastim in the Management of Chemotherapy-induced Neutropenia of Cancer Patients

   R. Guariglia, M. Martorelli, R. Lerose, D. Telesca +2 more

   25 citations

   Semantic Scholar

   Save

9. No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura.

   G. D'Arena, R. Guariglia, G. Mansueto, M. Martorelli +4 more

   2013Blood22 citations

   Semantic Scholar

   Save

10. An NMR Study of the Bortezomib Degradation under Clinical Use Conditions

    A. Bolognese, Annamaria Esposito, M. Manfra, L. Catalano +7 more

    2009Advances in Hematology18 citations Open access

    Semantic Scholar

    Save

11. Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study

    D. De Novellis, R. Fontana, A. Carobene, B. Serio +10 more

    2022Biomedicines12 citations Open access

    Semantic Scholar

    Save

12. Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens

    L. Pezzullo, Valentina Giudice, B. Serio, R. Fontana +11 more

    2021Open Medicine12 citations Open access

    Semantic Scholar

    Save

13. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?

    G. D'Arena, Marica Gemei, L. Luciano, F. D'Auria +11 more

    2012Journal of Clinical Oncology12 citations Open access

    Semantic Scholar

    Save

14. Detection of increased left ventricular filling pressure by pulsed tissue Doppler in cardiac amyloidosis

    P. Innelli, M. Galderisi, L. Catalano, M. Martorelli +4 more

    2006Journal of Cardiovascular Medicine12 citations

    Semantic Scholar

    Save

15. Final Results of a Phase II Study Evaluating Lenalidomide in Combination with Low Dose Dexamethasone As First Line Therapy for Primary Plasma Cell Leukemia

    P. Musto, F. D'Auria, M. Petrucci, A. Levi +26 more

    201111 citations

    Semantic Scholar

    Save

16. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.

    B. Serio, Valentina Giudice, R. Guariglia, R. Fontana +8 more

    2021Le infezioni in medicina9 citations

    Semantic Scholar

    Save

17. An Urologic Face of Chronic Lymphocytic Leukemia: Sequential Prostatic and Penis Localization

    G. D'Arena, R. Guariglia, O. Villani, M. Martorelli +10 more

    2013Mediterranean Journal of Hematology and Infectious Diseases7 citations Open access

    Semantic Scholar

    Save

18. A double blind, placebo controlled trial of efficacy and safety of oral acyclovir (Zovirax) in the treatment of chickenpox in adults.

    M. Andreoni, M. Canfarini, P. C. Grint, M. Martorelli +2 more

    1992Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques5 citations

    Semantic Scholar

    Save

19. How Epidemiology of Polycythemia Vera Has Changed in the Last 10 Years: Results From the Whole Prospective Cohort of Patients in Cyto-PV Trial As Compared with Eclap Prospective Cohort

    A. Masciulli, T. Barbui, R. Marfisi, Riccardo Cavazzina +27 more

    20124 citations

    Semantic Scholar

    Save

20. CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience

    L. Mettivier, D. De Novellis, A. D. Della Corte, B. Serio +10 more

    2025Frontiers in Oncology3 citations Open access

    Semantic Scholar

    Save

21. Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study

    M. Martorelli, N. Pugliese, M. Di Perna, D. De Novellis +31 more

    2025European Journal of Haematology3 citations Open access

    Semantic Scholar

    Save

22. Biclonality in hairy cell leukemia: Co‐occurrence of CD10+ and CD10− clones with different surface membrane immunoglobulin expression

    M. Gorrese, R. Guariglia, Annapaola Campana, A. Bertolini +5 more

    2022Cytometry. Part B, Clinical cytometry3 citations

    Semantic Scholar

    Save

23. A Large-Scale Trial Testing the Intensity of Cytoreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera (CYTO-PV trial)

    T. Barbui, M. Lunghi, A. Tieghi, G. Finazzi +26 more

    20123 citations

    Semantic Scholar

    Save

24. Final Analysis of a Multicenter, Randomised Study Comparing Zoledronate vs Observation in Patients with Asymptomatic Myeloma.

    P. Musto, M. Petrucci, S. Bringhen, T. Guglielmelli +14 more

    20073 citations

    Semantic Scholar

    Save

25. Real-World Use and Outcome of Ropeginterferon ALFA-2B in Polycythemia VERA Patients: A Multicenteric Study

    N. Pugliese, M. Di Perna, Ugo De Martino, V. Amico +9 more

    2024Blood2 citations

    Semantic Scholar

    Save

26. More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection

    G. D'Arena, R. Guariglia, G. Pietrantuono, O. Villani +6 more

    2014Leukemia and Lymphoma2 citations

    Semantic Scholar

    Save

27. Modification of QRS pattern in a patient with AL amyloidosis.

    G. Gallucci, R. Guariglia, Rodolfo Cangiano, G. Mansueto +2 more

    2013International Journal of Cardiology2 citations

    Semantic Scholar

    Save

28. Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients.

    P. Musto, V. Fraticelli, G. Mansueto, G. D'Arena +28 more

    20122 citations

    Semantic Scholar

    Save

29. Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients

    D. De Novellis, V. Folliero, Valentina Giudice, L. Pezzullo +20 more

    2023Clinical and Experimental Medicine (Testo stampato)1 citations Open access

    Semantic Scholar

    Save

30. Lenalidomide and Low Dose Dexamethasone As First Line Therapy for Newly Diagnosed Patients with Primary Plasma Cell Leukemia

    P. Musto, V. Simeon, G. D'Arena, M. Martorelli +27 more

    20121 citations

    Semantic Scholar

    Save

31. A Pilot Study of Lenalidomide and Dexamethasone as First Line Therapy in Patients with Primary Plasma Cell Leukemia.

    P. Musto, M. Petrucci, F. Morabito, F. Nobile +15 more

    20091 citations

    Semantic Scholar

    Save

32. Bortezomib as Front-Line Therapy in Primary Plasma Cell Leukemia

    G. Pietrantuono, R. Guariglia, O. Villani, M. Martorelli +15 more

    20081 citations

    Semantic Scholar

    Save

33. Darbepoetin 500 mcg Q3W, Alone or in Combination with Peg-Filgrastim, in Low/Int1 IPSS Risk Myelodysplastic Syndromes Unresponsive to Recombinant Erythropoietin.

    O. Villani, R. Guariglia, G. Pietrantuono, M. Martorelli +6 more

    20071 citations

    Semantic Scholar

    Save

34. Combination of Rituximab, Bortezomib and Hyper-Fractionated Cyclophosphamide (RBC) in “True” Elderly Patients with Advanced Mantle Cell Lympoma.

    R. Guariglia, G. Pietrantuono, O. Villani, M. Martorelli +10 more

    20071 citations

    Semantic Scholar

    Save

35. Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies

    P. Scala, A. D. Della Corte, A. Bertolini, M. Gorrese +11 more

    2026International Journal of Laboratory Hematology0 citations Open access

    Semantic Scholar

    Save

36. Impact of early dose escalation and treatment duration on hematologic response in ropeginterferon alfa-2b treatment for polycythemia vera

    N. Pugliese, A. Duminuco, H. Catellani, M. Di Perna +9 more

    2025Blood0 citations

    Semantic Scholar

    Save

37. CD38 Expression As an Additional Prognostic Marker in Mantle Cell Lymphoma

    M. D’addona, L. Pezzullo, Valentina Giudice, D. De Novellis +14 more

    2024Blood0 citations

    Semantic Scholar

    Save

38. Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors

    Valentina Giudice, M. Gorrese, I. Ferrara, R. Pepe +10 more

    2021Blood0 citations Open access

    Semantic Scholar

    Save

39. INCREASED CYTOMEGALOVIRUS (CMV) REACTIVATION IN PATIENTS TREATED WITH BENDAMUSTINE BASED REGIMEN IS CORRELATE WITH DRAMATICAL REDUCTION OF CD4+ T LYMPHOCITES

    L. Pezzullo, A. Bruno, G. Cassiodoro, R. Bianco +8 more

    2019Hematological Oncology0 citations

    Semantic Scholar

    Save

40. PS1270 HIGH INCIDENCE OF CYTOMEGALOVIRUS (CMV) REACTIVATION IN HEMATOLOGICAL PATIENTS TREATED WITH BENDAMUSTINE BASED CHEMOTERAPY REGIMENS

    L. Pezzullo, Rosa Rosamilio, R. Guariglia, A. Bruno +7 more

    2019HemaSphere0 citations Open access

    Semantic Scholar

    Save

41. P 11 Endocannabinoids in chronic alcoholic liver disease

    A. Porcu, M. Martorelli, M. Melis, C. Ullrich +5 more

    20170 citations

    Semantic Scholar

    Save

42. 205 Circulating regulatory T cells (Tregs) in myelodysplastic syndromes (MDS)

    T. Statuto, F. D'Auria, R. Guarglia, G. Pietrantuono +4 more

    20110 citations

    Semantic Scholar

    Save

43. Efficacy of Lenalidomide in Primary Plasma Cell Leukemia.

    G. Pietrantuono, R. Guariglia, M. Martorelli, O. Villani +2 more

    20070 citations

    Semantic Scholar

    Save

44. Spontaneous seroconversion from HBeAg to anti-HBe is preceded and heralded by a progressive. Increase of 2′,5′-oligoadenylate (2′,5′-OAS) activity

    G. Saracco, S. Macagno, G. Actis, F. Rosina +3 more

    19890 citations

    Semantic Scholar

    Save